Gutiérrez-de-Terán H - Search Results

1

3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A_2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition.

Majellaro M, Jespers W, Crespo A, Núñez MJ, Novio S, Azuaje J, Prieto-Díaz R, Gioé C, Alispahic B, Brea J, Loza MI, Freire-Garabal M, Garcia-Santiago C, Rodríguez-García C, García-Mera X, Caamaño O, Fernandez-Masaguer C, Sardina JF, Stefanachi A, El Maatougui A, Mallo-Abreu A, Åqvist J, Gutiérrez-de-Terán H, Sotelo E. Majellaro M, et al. J Med Chem. 2021 Jan 14;64(1):458-480. doi: 10.1021/acs.jmedchem.0c01431. Epub 2020 Dec 29. J Med Chem. 2021. PMID: 33372800

2

Comparative analysis of putative agonist-binding modes in the human A1 adenosine receptor.

Gutiérrez-de-Terán H, Pastor M, Centeno NB, Aqvist J, Sanz F. Gutiérrez-de-Terán H, et al. Chembiochem. 2004 Jun 7;5(6):841-9. doi: 10.1002/cbic.200300817. Chembiochem. 2004. PMID: 15174168

3

Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.

Gutiérrez-de-Terán H, Nervall M, Ersmark K, Liu P, Janka LK, Dunn B, Hallberg A, Aqvist J. Gutiérrez-de-Terán H, et al. Biochemistry. 2006 Sep 5;45(35):10529-41. doi: 10.1021/bi0609669. Biochemistry. 2006. PMID: 16939205

4

Computational analysis of plasmepsin IV bound to an allophenylnorstatine inhibitor.

Gutiérrez-de-Terán H, Nervall M, Dunn BM, Clemente JC, Aqvist J. Gutiérrez-de-Terán H, et al. FEBS Lett. 2006 Oct 30;580(25):5910-6. doi: 10.1016/j.febslet.2006.09.057. Epub 2006 Oct 5. FEBS Lett. 2006. PMID: 17045991 Free article.

5

Computational inhibitor design against malaria plasmepsins.

Bjelic S, Nervall M, Gutiérrez-de-Terán H, Ersmark K, Hallberg A, Aqvist J. Bjelic S, et al. Cell Mol Life Sci. 2007 Sep;64(17):2285-305. doi: 10.1007/s00018-007-7102-2. Cell Mol Life Sci. 2007. PMID: 17585371 Review.

6

Synthesis, adenosine receptor binding and 3D-QSAR of 4-substituted 2-(2'-furyl)-1,2,4-triazolo[1,5-a]quinoxalines.

Martínez A, Gutiérrez-de-Terán H, Brea J, Raviña E, Loza MI, Cadavid MI, Sanz F, Vidal B, Segarra V, Sotelo E. Martínez A, et al. Bioorg Med Chem. 2008 Feb 15;16(4):2103-13. doi: 10.1016/j.bmc.2007.10.103. Epub 2008 Jan 24. Bioorg Med Chem. 2008. PMID: 18249548

7

alpha-Substituted norstatines as the transition-state mimic in inhibitors of multiple digestive vacuole malaria aspartic proteases.

Orrling KM, Marzahn MR, Gutiérrez-de-Terán H, Aqvist J, Dunn BM, Larhed M. Orrling KM, et al. Bioorg Med Chem. 2009 Aug 15;17(16):5933-49. doi: 10.1016/j.bmc.2009.06.065. Epub 2009 Jul 3. Bioorg Med Chem. 2009. PMID: 19635672

8

Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.

Varin T, Gutiérrez-de-Terán H, Castro M, Brea J, Fabis F, Dauphin F, Aqvist J, Lepailleur A, Perez P, Burgueño J, Vela JM, Loza MI, Rodrigo J. Varin T, et al. Br J Pharmacol. 2010 Mar;159(5):1069-81. doi: 10.1111/j.1476-5381.2009.00481.x. Epub 2009 Nov 18. Br J Pharmacol. 2010. PMID: 19922537 Free PMC article.

9

In silico directed chemical probing of the adenosine receptor family.

Areias FM, Brea J, Gregori-Puigjané E, Zaki ME, Carvalho MA, Domínguez E, Gutiérrez-de-Terán H, Proença MF, Loza MI, Mestres J. Areias FM, et al. Bioorg Med Chem. 2010 May 1;18(9):3043-52. doi: 10.1016/j.bmc.2010.03.048. Epub 2010 Mar 27. Bioorg Med Chem. 2010. PMID: 20382540

10

Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists.

Yaziji V, Rodríguez D, Gutiérrez-de-Terán H, Coelho A, Caamaño O, García-Mera X, Brea J, Loza MI, Cadavid MI, Sotelo E. Yaziji V, et al. J Med Chem. 2011 Jan 27;54(2):457-71. doi: 10.1021/jm100843z. Epub 2010 Dec 27. J Med Chem. 2011. PMID: 21186795

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page